Production (Stage)
Eupraxia Pharmaceuticals Inc.
EPRX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.45M | 33.10M | 8.66M | 23.32M | 35.91M |
| Total Receivables | 238.50K | 228.90K | 105.90K | 155.20K | 167.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 913.30K | 1.11M | 1.12M | 1.05M | 140.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 28.61M | 34.44M | 9.89M | 24.53M | 36.22M |
|
|
|||||
| Total Current Assets | 28.61M | 34.44M | 9.89M | 24.53M | 36.22M |
| Net Property, Plant & Equipment | 546.50K | 424.90K | 456.50K | 445.50K | 414.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 80.20K | 80.80K | 18.40K | 4.60K | 5.60K |
| Total Assets | 29.23M | 34.94M | 10.36M | 24.98M | 36.64M |
|
|
|||||
| Total Accounts Payable | -- | 3.03M | -- | -- | -- |
| Total Accrued Expenses | 2.10M | 3.01M | 2.27M | 1.95M | 3.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 52.80K | 71.90K | 78.80K | 4.63M | 9.56M |
| Total Finance Division Other Current Liabilities | 45.20K | 20.70K | 22.30K | 5.03M | 5.07M |
| Total Other Current Liabilities | 45.20K | 20.70K | 22.30K | 5.03M | 5.07M |
| Total Current Liabilities | 2.20M | 3.10M | 2.37M | 11.60M | 18.53M |
|
|
|||||
| Total Current Liabilities | 2.20M | 3.10M | 2.37M | 11.60M | 18.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 14.30K | 35.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | -- | -- | -- |
| Total Liabilities | 2.20M | 3.10M | 2.39M | 11.64M | 18.53M |
|
|
|||||
| Common Stock & APIC | 138.79M | 136.86M | 135.81M | 135.30M | 133.83M |
| Retained Earnings | -137.77M | -131.00M | -123.49M | -117.55M | -111.54M |
| Treasury Stock & Other | -4.12M | -4.16M | -2.79M | -2.92M | -2.74M |
| Total Common Equity | -3.10M | 1.70M | 9.52M | 14.83M | 19.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 31.71M | 31.71M | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 31.71M | 31.71M | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.10M | 1.70M | 9.52M | 14.83M | 19.54M |
| Total Preferred Equity | 31.71M | 31.71M | -- | -- | -- |
| Total Minority Interest | -1.57M | -1.57M | -1.54M | -1.49M | -1.44M |
| Total Equity | 27.03M | 31.84M | 7.98M | 13.34M | 18.11M |
|
|
|||||